Modeling Time-Dependent Recovery to Improve Esophagitis Prediction in Thoracic Reirradiation

利用时间依赖性恢复模型改进胸部再放射治疗后食管炎的预测

阅读:2

Abstract

PURPOSE: In reirradiation, tumor control must be balanced against a high-risk of adverse effects. We evaluated the feasibility of a time-dependent recovery model to improve toxicity prediction. METHODS AND MATERIALS: Sixty-five high-risk thoracic reirradiation patients, identified by BID treatment, were included for modeling grade ≥2 acute esophagitis. The median (range) re-RT dose was 45 Gy (30-60) in 30 (20-40) fractions. Doses from each course were deformably registered to the most recent CT and converted to voxel-wise equivalent dose in 2-Gy fractions. We compared the discrimination of the last course dose, conventional direct accumulation without time consideration, and 3 time-dependent recovery models-mono-exponential, bi-exponential, and reciprocal time-each optimized via grid search with nested 5-fold cross-validation. Logistic regression with bootstrapping was used to assess the predictive value of mean and maximum dose. AUCs were compared using a bootstrap test. Covariates (age, chemotherapy, smoking status, and history of esophagitis from a previous course of thoracic radiation therapy) were also evaluated. RESULTS: After BID re-RT, 26.2% (17/65) of patients experienced grade ≥2 esophagitis. Incorporating time-dependent repair algorithms achieved a higher AUC than the last course dose and direct accumulation. The bi-exponential model incorporating history of prior esophagitis achieved the highest performance (mean dose AUC: 0.83 [95% CI, 0.70-0.94] vs direct accumulation: 0.74 [0.61-0.87], P = .040; maximum dose AUC: 0.78 [0.65-0.89] vs 0.67 [0.54-0.80], P = .015). CONCLUSIONS: Incorporating time-dependent recovery into dose accumulation is feasible, and our findings support its potential use over direct accumulation for more accurate toxicity prediction. These findings will pave the way for developing advanced outcome models for evidence-based reirradiation, ultimately reducing toxicity and optimizing doses for personalized and effective reirradiation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。